<DOC>
	<DOCNO>NCT02197559</DOCNO>
	<brief_summary>The study hypothesize Drug -eluting stent effective prevent restenosis Bare-metal stent Vertebral Artery Ostium stenting</brief_summary>
	<brief_title>Bare -Metal Stents Drug -Eluting Stents Treatment Patients With Vertebral Artery Ostium Stenosis</brief_title>
	<detailed_description>The vertebral artery ostium stenosis one high risk ischemia stroke China . In mean time , people accept revascularization . There prospective study comparison prevention restenosis Drug -eluting stent Bare-metal stent . The main aim study observe follow detail : 1 . Late loss lumen diameter follow-up ≥50 % 2 . Death , non -fatal stroke 30 day stent implantation associate antiplatelet drug 3 . Death , non -fatal stroke 12 month stent implantation associate antiplatelet drug Secondary endpoint : brain , gastrointestinal urinary system bleed 12 month follow-up</detailed_description>
	<criteria>symptomatic posterior circulation ischemia include monor stroke ( mRS ≤2 ) TIA result stenosis vertebral artery ostium . 70 % 99 % stenosis vertebral artery ostium . etiology stenotic lesion atherosclerosis patient undergone previos intervention vertebral artery ostium ipsilateral severe stenotic lesion subclavian artery involve well vertebral artery ostium</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Ischemic Stroke , restenosis , bare-metal stent , drug -eluting stent</keyword>
</DOC>